Loading article…
Jan O. Korbel (born 1975) is a German scientist working in the fields of human genetics, genomics and computational biology. He is the Interim Head of Site of the European Molecular Biology Laboratory (EMBL) site in Heidelberg, Germany.
After receiving his PhD in 2005 from Humboldt University of Berlin, he pursued his postdoctoral research at Yale University, New Haven, Connecticut (USA) with Mark B. Gerstein.[1]
He is a tenured principal investigator, and also Heading the Data Science Centre at the EMBL. He is also a senior scientist in the Genome Biology Unit at the EMBL, is leading a bridging research division at the German Cancer Research Center (DKFZ), and is an honorary professor ("Honorarprofessor") at Heidelberg University. A particular focus of the Korbel group is on investigating a particular form of mutation, genomic structural variation, which includes deletions, inversions and more complex chromosomal rearrangements such as chromothripsis events that can occur in healthy individuals and in context of disease. His group's principal research objective is to understand genomic structural variations as a basis of phenotypic variation and cancer development.[2]
In addition to his research activities, Jan Korbel is promoting interdisciplinary dialogues in bioethics,[3] and the application of genome sequencing in Genomic Medicine.[4]
He received several academic prizes, including:
彼はドイツ国立科学アカデミーレオポルディーナ[ 9 ]（2015年）および欧州分子生物学機構（EMBO）[ 10 ] （2016年）の選出会員である。また、欧州がん科学アカデミーのフェローでもある[ 11 ]。ヤン・コルベルは欧州研究会議（ERC）の研究員でもある[ 12 ] 。